{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T02:35:48Z","timestamp":1784082948142,"version":"3.55.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T00:00:00Z","timestamp":1673395200000},"content-version":"vor","delay-in-days":2293,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["mp.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Modern Pathology"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1038\/modpathol.2016.118","type":"journal-article","created":{"date-parts":[[2016,7,22]],"date-time":"2016-07-22T07:45:26Z","timestamp":1469173526000},"page":"1221-1231","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Acute erythroid leukemia with &lt;20% bone marrow blasts is clinically and biologically similar to myelodysplastic syndrome with excess blasts"],"prefix":"10.1016","volume":"29","author":[{"given":"Sa A","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keyur P","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Pozdnyakova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuang","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola Dal","family":"Cin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David P","family":"Steensma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert P","family":"Hasserjian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/modpathol.2016.118_bib1","doi-asserted-by":"crossref","first-page":"3835","DOI":"10.1200\/JCO.1999.17.12.3835","article-title":"World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee Meeting-Airlie House, Virginia, November 1997","volume":"17","author":"Harris","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1038\/modpathol.2016.118_bib2","doi-asserted-by":"crossref","first-page":"620","DOI":"10.7326\/0003-4819-103-4-620","article-title":"Proposed revised criteria for the classification of acute myeloid leukemia: a report of the French-American-British Cooperative Group","volume":"103","author":"Bennett","year":"1985","journal-title":"Ann Intern Med"},{"key":"10.1038\/modpathol.2016.118_bib3","doi-asserted-by":"crossref","first-page":"568","DOI":"10.3324\/haematol.2012.071449","article-title":"Reproducibility of the World Health Organization 2008 criteria for myelodysplastic syndromes","volume":"98","author":"Senent","year":"2013","journal-title":"Haematologica"},{"key":"10.1038\/modpathol.2016.118_bib4","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1038\/modpathol.2008.142","article-title":"Erythroid-predominant myelodysplastic syndromes: enumeration of blasts from nonerythroid rather than total marrow cells provides superior risk stratification","volume":"21","author":"Wang","year":"2008","journal-title":"Mod Pathol"},{"key":"10.1038\/modpathol.2016.118_bib5","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1038\/leu.2009.181","article-title":"Adult acute erythroleukemia: an analysis of 91 patients treated at a single institution","volume":"23","author":"Santos","year":"2009","journal-title":"Leukemia"},{"key":"10.1038\/modpathol.2016.118_bib6","doi-asserted-by":"crossref","first-page":"812","DOI":"10.3109\/10428194.2015.1079318","article-title":"Myelodysplastic syndromes following therapy with hypomethylating agents (HMAs): development of acute erythroleukemia may not influence assessment of treatment response","volume":"57","author":"Peng","year":"2016","journal-title":"Leuk Lymphoma"},{"key":"10.1038\/modpathol.2016.118_bib7","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1309\/AJCPRKYAT6EZQHC7","article-title":"Acute erythroleukemias, acute megakaryoblastic leukemias, and reactive mimics: a guide to a number of perplexing entities","volume":"144","author":"Wang","year":"2015","journal-title":"Am J Clin Pathol"},{"key":"10.1038\/modpathol.2016.118_bib8","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1038\/modpathol.2010.96","article-title":"Acute erythroid leukemia as defined in the World Health Organization classification is a rare and pathogenetically heterogeneous disease","volume":"23","author":"Kasyan","year":"2010","journal-title":"Mod Pathol"},{"key":"10.1038\/modpathol.2016.118_bib9","doi-asserted-by":"crossref","first-page":"e41485","DOI":"10.1371\/journal.pone.0041485","article-title":"Acute myeloid leukemia (AML) with erythroid predominance exhibits clinical and molecular characteristics that differ from other types of AML","volume":"7","author":"Zuo","year":"2012","journal-title":"PloS ONE"},{"key":"10.1038\/modpathol.2016.118_bib10","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1038\/leu.2013.144","article-title":"Acute erythroid leukemia (AEL) can be separated into distinct prognostic subsets based on cytogenetic and molecular genetic characteristics","volume":"27","author":"Grossmann","year":"2013","journal-title":"Leukemia"},{"key":"10.1038\/modpathol.2016.118_bib11","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1002\/cncr.22496","article-title":"A comparison of low-dose cytarabine and hydroxyurea with or without all-trans retinoic acid for acute myeloid leukemia and high-risk myelodysplastic syndrome in patients not considered fit for intensive treatment","volume":"109","author":"Burnett","year":"2007","journal-title":"Cancer"},{"key":"10.1038\/modpathol.2016.118_bib12","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1200\/JCO.2011.35.6394","article-title":"New comprehensive cytogenetic scoring system for primary myelodysplastic syndromes (MDS) and oligoblastic acute myeloid leukemia after MDS derived from an international database merge","volume":"30","author":"Schanz","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1038\/modpathol.2016.118_bib13","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.leukres.2014.12.006","article-title":"Mutational profiling of therapy-related myelodysplastic syndromes and acute myeloid leukemia by next generation sequencing, a comparison with de novo diseases","volume":"39","author":"Ok","year":"2015","journal-title":"Leuk Res"},{"key":"10.1038\/modpathol.2016.118_bib14","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s13045-015-0139-z","article-title":"TP53 mutation characteristics in therapy-related myelodysplastic syndromes and acute myeloid leukemia is similar to de novo diseases","volume":"8","author":"Ok","year":"2015","journal-title":"J Hematol Oncol"},{"key":"10.1038\/modpathol.2016.118_bib15","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1038\/modpathol.2014.153","article-title":"High p53 protein expression in therapy-related myeloid neoplasms is associated with adverse karyotype and poor outcome","volume":"28","author":"Cleven","year":"2015","journal-title":"Mod Pathol"},{"key":"10.1038\/modpathol.2016.118_bib16","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1182\/blood.V80.11.2873.2873","article-title":"Clinical, morphologic, and cytogenetic characteristics of 26 patients with acute erythroblastic leukemia","volume":"80","author":"Olopade","year":"1992","journal-title":"Blood"},{"key":"10.1038\/modpathol.2016.118_bib17","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1182\/blood-2009-09-243964","article-title":"Acute erythroid leukemia: a reassessment using criteria refined in the 2008 WHO classification","volume":"115","author":"Hasserjian","year":"2010","journal-title":"Blood"},{"key":"10.1038\/modpathol.2016.118_bib18","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/modpathol.2010.194","article-title":"Pure erythroid leukemia: a reassessment of the entity using the 2008 World Health Organization classification","volume":"24","author":"Liu","year":"2011","journal-title":"Mod Pathol"},{"key":"10.1038\/modpathol.2016.118_bib19","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.3324\/haematol.2011.043687","article-title":"Comparison of genetic and clinical aspects in patients with acute myeloid leukemia and myelodysplastic syndromes all with more than 50% of bone marrow erythropoietic cells","volume":"96","author":"Bacher","year":"2011","journal-title":"Haematologica"},{"key":"10.1038\/modpathol.2016.118_bib20","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/S0145-2126(96)00110-5","article-title":"Morphological changes and apoptosis in bone marrow from patients with myelodysplastic syndromes treated with granulocyte-CSF and erythropoietin","volume":"21","author":"Hellstrom-Lindberg","year":"1997","journal-title":"Leuk Res"},{"key":"10.1038\/modpathol.2016.118_bib21","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1136\/jclinpath-2014-202740","article-title":"How unique is pure erythroid leukaemia? A retrospective analysis of seven cases and review of the literature","volume":"68","author":"Wong","year":"2015","journal-title":"J Clin Pathol"},{"key":"10.1038\/modpathol.2016.118_bib22","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1309\/AJCPD85MCOHHCOMQ","article-title":"Therapy-related myeloid neoplasms","volume":"132","author":"Czader","year":"2009","journal-title":"Am J Clin Pathol"},{"key":"10.1038\/modpathol.2016.118_bib23","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1136\/jcp.54.8.608","article-title":"Erythroleukaemia in the north of England: a population based study","volume":"54","author":"Wells","year":"2001","journal-title":"J Clin Pathol"},{"key":"10.1038\/modpathol.2016.118_bib24","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1182\/blood-2012-03-420489","article-title":"Revised international prognostic scoring system for myelodysplastic syndromes","volume":"120","author":"Greenberg","year":"2012","journal-title":"Blood"},{"key":"10.1038\/modpathol.2016.118_bib25","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S1470-2045(09)70003-8","article-title":"Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study","volume":"10","author":"Fenaux","year":"2009","journal-title":"Lancet Oncol"},{"key":"10.1038\/modpathol.2016.118_bib26","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1200\/JCO.2009.23.8329","article-title":"Azacitidine prolongs overall survival compared with conventional care regimens in elderly patients with low bone marrow blast count acute myeloid leukemia","volume":"28","author":"Fenaux","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1038\/modpathol.2016.118_bib27","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/ejh.12549","article-title":"Chronic myelomonocytic leukemia with nucleophosmin (NPM1) mutation","volume":"96","author":"Peng","year":"2016","journal-title":"Eur J Haematol"},{"key":"10.1038\/modpathol.2016.118_bib28","doi-asserted-by":"crossref","first-page":"4533","DOI":"10.1200\/JCO.2012.44.3499","article-title":"Impact of azacitidine before allogeneic stem-cell transplantation for myelodysplastic syndromes: a study by the Societe Francaise de Greffe de Moelle et de Therapie-Cellulaire and the Groupe-Francophone des Myelodysplasies","volume":"30","author":"Damaj","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1038\/modpathol.2016.118_bib29","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/j.bbmt.2012.01.009","article-title":"Pretransplantation therapy with azacitidine vs induction chemotherapy and posttransplantation outcome in patients with MDS","volume":"18","author":"Gerds","year":"2012","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1038\/modpathol.2016.118_bib30","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1182\/blood-2016-03-643544","article-title":"The 2016 revision to the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia","volume":"127","author":"Arber","year":"2016","journal-title":"Blood"}],"container-title":["Modern Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/modpathol2016118.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/modpathol2016118","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S089339522201540X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S089339522201540X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/modpathol2016118.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T00:49:28Z","timestamp":1760230168000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S089339522201540X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":30,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["S089339522201540X"],"URL":"https:\/\/doi.org\/10.1038\/modpathol.2016.118","relation":{},"ISSN":["0893-3952"],"issn-type":[{"value":"0893-3952","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Acute erythroid leukemia with <20% bone marrow blasts is clinically and biologically similar to myelodysplastic syndrome with excess blasts","name":"articletitle","label":"Article Title"},{"value":"Modern Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/modpathol.2016.118","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 United States & Canadian Academy of Pathology.","name":"copyright","label":"Copyright"}]}}